These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6447474)
1. Mezlocillin for treatment of infections in cancer patients. Issell BF; Bodey GP Antimicrob Agents Chemother; 1980 Jun; 17(6):1008-13. PubMed ID: 6447474 [TBL] [Abstract][Full Text] [Related]
2. Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients. Wade JC; Schimpff SC; Newman KA; Fortner CL; Moody MR; Young VM; Wiernik PH Antimicrob Agents Chemother; 1980 Aug; 18(2):299-306. PubMed ID: 6449902 [TBL] [Abstract][Full Text] [Related]
3. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies. Lawson RD; Gentry LO; Bodey GP; Keating MJ; Smith TL Am J Med Sci; 1984; 287(1):16-23. PubMed ID: 6367466 [TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections. Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296 [TBL] [Abstract][Full Text] [Related]
5. Mezlocillin in the therapy of serious infections. Pancoast SJ; Jahre JA; Neu HC Am J Med; 1979 Nov; 67(5):747-52. PubMed ID: 507086 [TBL] [Abstract][Full Text] [Related]
6. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins. Eliopoulos GM; Moellering RC Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872 [TBL] [Abstract][Full Text] [Related]
8. Empiric antibiotic treatment of infections in myelosuppressed cancer patients. Preliminary results. Hellriegel KP; Kindler J; Wittenberg C; Kress M Infection; 1982; 10 Suppl 3():S138-40. PubMed ID: 6218101 [TBL] [Abstract][Full Text] [Related]
9. Synergistic action between sisomicin and mezlocillin against gram-negative bacteria and Staphylococcus aureus. Soares LA; Trabulsi LR Arzneimittelforschung; 1979; 29(12a):1934-7. PubMed ID: 543894 [TBL] [Abstract][Full Text] [Related]
10. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients. Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817 [TBL] [Abstract][Full Text] [Related]
12. Clinical study of mezlocillin for the treatment and prevention of postoperative obstetric and gynecological infections. Ragni N Clin Ther; 1982; 4(5):413-6. PubMed ID: 6461413 [TBL] [Abstract][Full Text] [Related]
13. Comparison of mezlocillin and carbenicillin as therapy for various infectious diseases. Rolandi E; Barreca T; Ragni N; Valente U; Sannia A; Fontana I; Magnani G; Salvini P Clin Ther; 1981; 4(4):321-5. PubMed ID: 6460558 [TBL] [Abstract][Full Text] [Related]
14. Timentin in combination with tobramycin as empirical therapy in febrile neutropenic patients with haematological malignancies. Krieger O; Bernhart M; Plohowich R; Nemec H; Lutz D J Antimicrob Chemother; 1986 May; 17 Suppl C():211-7. PubMed ID: 3636336 [TBL] [Abstract][Full Text] [Related]
18. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin. Russo J; Russo ME Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627 [TBL] [Abstract][Full Text] [Related]
19. Microbiology, pharmacology, and clinical use of mezlocillin sodium. McCloskey RV; LeFrock JL; Smith BR; Aronoff GR Pharmacotherapy; 1982; 2(6):300-12. PubMed ID: 6220263 [TBL] [Abstract][Full Text] [Related]
20. [Experience with the combination mezlocillin/oxacillin in severe bacterial infections in a children's surgical ward (author's transl)]. Kurz R Arzneimittelforschung; 1979; 29(12a):2014-7. PubMed ID: 543915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]